ARTICLE | Clinical News
Biomatrix regulatory update
October 2, 1995 7:00 AM UTC
The FDA accepted for filing BIOX's PMA for Hylaform, a hylan B polymer, as a potential treatment to correct facial wrinkles and depressed scars. The Ridgefield, N.J., company submitted the applicatio...